Pediatric hypertension: A guideline update.
Journal
The Nurse practitioner
ISSN: 1538-8662
Titre abrégé: Nurse Pract
Pays: United States
ID NLM: 7603663
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
pubmed:
10
4
2020
medline:
19
5
2020
entrez:
10
4
2020
Statut:
ppublish
Résumé
The prevalence of pediatric hypertension is growing. Hypertension during childhood remains a major risk factor for adverse cardiovascular events later in life. NPs should be aware of current guidelines on screening, diagnosis, and treatment of hypertension in children to improve care for this patient population.
Identifiants
pubmed: 32271260
doi: 10.1097/01.NPR.0000660332.31690.68
pii: 00006205-202005000-00005
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
16-23Références
Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904.
Gupta-Malhotra M, Hashmi SS, Poffenbarger T, McNiece-Redwine K. Left ventricular hypertrophy phenotype in childhood-onset essential hypertension. J Clin Hypertens (Greenwich). 2016;18(5):449–455.
Yang L, Yang L, Zhang Y, Xi B. Prevalence of target organ damage in Chinese hypertensive children and adolescents. Front Pediatr. 2018;6:333.
Leiba A, Twig G, Levine H, et al. Hypertension in late adolescence and cardiovascular mortality in midlife: a cohort study of 2.3 million 16- to 19-year-old examinees. Pediatr Nephrol. 2016;31(3):485–492.
Matossian D. Pediatric hypertension. Pediatr Ann. 2018;47(12):e499–e503.
Hanevold CD, Flynn JT. Hypertension in children: diagnosis and treatment. In: Hypertension: A Companion to Braunwald's Heart Disease E-Book. 3rd ed. Philadelphia, PA: Elsevier; 2018.
Song P, Zhang Y, Yu J, et al. Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr. 2019:1–10.
Taylor-Zapata P, Baker-Smith CM, Burckart G, et al. Research gaps in primary pediatric hypertension. Pediatrics. 2019;143(5):e20183517.
Guzman-Limon M, Samuels J. Pediatric hypertension: diagnosis, evaluation, and treatment. Pediatr Clin North Am. 2019;66(1):45–57.
Vieux R, Gerard M, Roussel A, et al. Kidneys in 5-year-old preterm-born children: a longitudinal cohort monitoring of renal function. Pediatr Res. 2017;82(6):979–985.
Batisky DL. Obesity hypertension: clinical aspects. In: Flynn J, Ingelfinger JR, Redwine K, eds. Pediatric Hypertension. 4th ed. Switzerland: Springer International Publishing; 2017:1–19.
Parker ED, Sinaiko AR, Kharbanda EO, et al. Change in weight status and development of hypertension. Pediatrics. 2016;137(3):e20151662.
Gupta-Malhotra M, Banker A, Shete S, et al. Essential hypertension vs. secondary hypertension among children. Am J Hypertens. 2015;28(1):73–80.
American Academy of Pediatrics. Recommendations for preventive pediatric health care. Bright Futures. 2019. www.aap.org/en-us/documents/periodicity_schedule.pdf.
Hanevold CD. White coat hypertension in children and adolescents. Hypertension. 2019;73(1):24–30.
Ahern D, Dixon E. Pediatric hypertension: a growing problem. Prim Care. 2015;42(1):143–150.
Kelly RK, Thomson R, Smith KJ, Dwyer T, Venn A, Magnussen CG. Factors affecting tracking of blood pressure from childhood to adulthood: the childhood determinants of adult health study. J Pediatr. 2015;167(6):1422–1428.e2.
Centers for Disease Control and Prevention. Physical activity guidelines for school-aged children and adolescents. 2018. www.cdc.gov/healthyschools/physicalactivity/guidelines.htm.
Waldron FA, Benenson I, Jones-Dillon SA, et al. Prevalence and risk factors for hypertensive crisis in a predominantly African American inner-city community. Blood Press. 2019;28(2):114–123.
Husain K, Ansari RA, Ferder L. Alcohol-induced hypertension: mechanism and prevention. World J Cardiol. 2014;6(5):245–252.
Burrello J, Erhardt EM, Saint-Hilary G, et al. Pharmacological treatment of arterial hypertension in children and adolescents: a network meta-analysis. Hypertension. 2018;72(2):306–313.
Gartenmann AC, Fossali E, von Vigier RO, et al. Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood. Kidney Int. 2003;64(4):1450–1454.